Table 5.
Symptoms presented by individuals in the acute phase of COVID-19 according to IgG persistence 90 days after diagnosis
| Symptoms | 2nd IgG | p* | ||
|---|---|---|---|---|
| N | Persistent n = 87 n (%) |
Nonpersistent n = 38 n (%) |
||
| Fever | 80 | 60 (69.0) | 20 (52.6) | 0.1052 |
| Headache | 89 | 63 (72.4) | 26 (68.4) | 0.6718 |
| Coryza | 60 | 45 (51.7) | 15 (39.4) | 0.2453 |
| Cough | 80 | 61 (70.1) | 18 (47.3) | 0.0257 |
| Sore throat | 66 | 47 (54.6) | 19 (50.0) | 0.7011 |
| Body pain | 90 | 66 (75.8) | 24 (63.1) | 0.1935 |
| Abdominal pain | 32 | 26 (29.8) | 6 (15.8) | 0.1207 |
| Diarrhea | 61 | 45 (51.7) | 16 (42.1) | 0.3385 |
| Vomiting | 19 | 14 (16.1) | 2 (5.3) | 0.1448 |
| Nausea | 37 | 30 (34.4) | 7 (18.2) | 0.0891 |
| Anosmia | 90 | 66 (75.9) | 24 (63.2) | 0.3713 |
| Ageusia | 86 | 63 (72.4) | 23 (60.5) | 0.8447 |
| Shortness of breath | 60 | 46 (52.8) | 14 (36.8) | 0.1208 |
| Hair loss | 47 | 36 (41.0) | 11 (28.9) | 0.2303 |
*Fisher’s exact test